Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap9.47B
Enterprise Value9.52B
P/E Ratio-116.8
PEG Ratio0.07
Price/Sales Ratio4.83
Price/Book Ratio1.89
Enterprise/Revenue4.96
Enterprise/EBITDA62.89

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.09
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue1.86B
Revenue/Share1.26
Gross Profit454.76M
EBITDA330.31M
Net Income-91.08M
Diluted EPS-0.06

Balance Sheet

Total Cash1.08B
Total Cash/Share0.69
Total Debt1.28B
Total Debt/Equity0.27
Current Ratio1.14
Book Value Per Share3.08

Price History

52-Week Change1.21
52-Week High9.09
52-Week Low4.87
Moving Average 50 Days5.67
Moving Average 200 Days6.17

Statistics

Average Volume21.65M
Shares Outstanding1.62B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.15
Last Split Factor2:1
Last Split DateMarch 01, 2016
AD